DrugPatentWatch Database Preview
Actavis Elizabeth Company Profile
» See Plans and Pricing
What is the competitive landscape for ACTAVIS ELIZABETH, and what generic and branded alternatives to ACTAVIS ELIZABETH drugs are available?
ACTAVIS ELIZABETH has one hundred and seventeen approved drugs.
There are six tentative approvals on ACTAVIS ELIZABETH drugs.
Summary for Actavis Elizabeth
| US Patents: | 0 |
| Tradenames: | 76 |
| Ingredients: | 76 |
| NDAs: | 117 |
| Patent Litigation for Actavis Elizabeth: | See patent lawsuits for Actavis Elizabeth |
| PTAB Cases with Actavis Elizabeth as petitioner: | See PTAB cases with Actavis Elizabeth as petitioner |
Drugs and US Patents for Actavis Elizabeth
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Elizabeth | ROPINIROLE HYDROCHLORIDE | ropinirole hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 090869-002 | May 17, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Actavis Elizabeth | PRAMIPEXOLE DIHYDROCHLORIDE | pramipexole dihydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201963-001 | Apr 21, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Actavis Elizabeth | TRAMADOL HYDROCHLORIDE | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 091609-002 | Jun 27, 2012 | AB2 | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
